Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/3/12 → 03/25/16 |
Funding
- Merck Sharp and Dohme Limited Liability Corporation: $4,400.00
A Phase III, Randomized, Placebo-Controlled, Clinical Trial t Study the Safety and Efficacy, of V212 in Adult Patients with Solid Tumor or Hematopoietic Malignancy
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Richard, Shambavi (CoPI)
Project: Research